148 related articles for article (PubMed ID: 38441601)
21. Effectiveness and Safety of Recombinant Human Follicle-Stimulating Hormone (Follitrope™) in Inducing Controlled Ovarian Stimulation in Infertile Women in Real-World Practice: a Prospective Cohort Study.
Choo CW; Ahn YS; Kim KH; Lee JH; Moon KY; Choi BC; Kang YJ; Kim HY; Sim CH; Han JE; Kim CH; Jang EJ; Lee Y; Moon JW; Park DS; Won HJ; Kim AN; Kim JY; Kim KR; Ahn JH; Lee JY; Gwak H; Kim JH
Reprod Sci; 2023 Sep; 30(9):2842-2852. PubMed ID: 37067727
[TBL] [Abstract][Full Text] [Related]
22. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer.
Brinsden P; Akagbosu F; Gibbons LM; Lancaster S; Gourdon D; Engrand P; Loumaye E
Fertil Steril; 2000 Jan; 73(1):114-6. PubMed ID: 10632423
[TBL] [Abstract][Full Text] [Related]
24. Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization.
Lisi F; Rinaldi L; Fishel S; Lisi R; Pepe G; Picconeri MG
Fertil Steril; 2003 Apr; 79(4):1037-8. PubMed ID: 12749452
[No Abstract] [Full Text] [Related]
25. Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing
Hu L; Zhang S; Quan S; Lv J; Qian W; Huang Y; Lu W; Sun Y
Aging (Albany NY); 2020 Mar; 12(6):4918-4930. PubMed ID: 32209728
[TBL] [Abstract][Full Text] [Related]
26. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
27. A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.
Jansen CA; van Os HC; Out HJ; Coelingh Bennink HJ
Hum Reprod; 1998 Nov; 13(11):2995-9. PubMed ID: 9853844
[TBL] [Abstract][Full Text] [Related]
28. Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap
Winstel R; Wieland J; Gertz B; Mueller A; Allgaier H
Drugs R D; 2017 Jun; 17(2):305-312. PubMed ID: 28386738
[TBL] [Abstract][Full Text] [Related]
29. Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles.
Strowitzki T; Kentenich H; Kiesel L; Neulen J; Bilger W
Hum Reprod; 1995 Dec; 10(12):3097-101. PubMed ID: 8822421
[TBL] [Abstract][Full Text] [Related]
30. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.
Tan SL; Child TJ; Cheung AP; Fluker MR; Yuzpe A; Casper R; Leung P; Cadesky K; Davis VJ
J Assist Reprod Genet; 2005 Feb; 22(2):81-8. PubMed ID: 15844733
[TBL] [Abstract][Full Text] [Related]
32. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).
Buckler HM; Robertson WR; Anderson A; Vickers M; Lambert A
Hum Reprod; 1999 Dec; 14(12):2969-73. PubMed ID: 10601080
[TBL] [Abstract][Full Text] [Related]
33. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone.
Esposito MA; Barnhart KT; Coutifaris C; Patrizio P
Fertil Steril; 2001 Mar; 75(3):519-24. PubMed ID: 11239535
[TBL] [Abstract][Full Text] [Related]
34. Effect of luteinizing hormone concentration on transcriptome and subcellular organelle phenotype of ovarian granulosa cells.
Wan YT; Liu S; Zhao SK; Luo YY; Lv YS; Qu DN; Liu MH; Li Y
J Assist Reprod Genet; 2021 Apr; 38(4):809-824. PubMed ID: 33447950
[TBL] [Abstract][Full Text] [Related]
35. Long-acting FSH versus daily FSH for women undergoing assisted reproduction.
Pouwer AW; Farquhar C; Kremer JA
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009577. PubMed ID: 26171903
[TBL] [Abstract][Full Text] [Related]
36. Serum Stem Cell Factor Assay in Elderly Poor Responder Patients Undergoing IVF: A New Biomarker to Customize Follicle Aspiration Cycle by Cycle.
Gizzo S; Quaranta M; Andrisani A; Bordin L; Vitagliano A; Esposito F; Venturella R; Zicchina C; Gangemi M; Noventa M
Reprod Sci; 2016 Jan; 23(1):61-8. PubMed ID: 26156851
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
39. The association between age-related infertility and deoxyribonucleic acid (DNA) integrity parameters of granulosa cells and lymphocytes.
Tola EN; Aslan Koşar P; Nal Sahin E; Sancer O
J Obstet Gynaecol; 2022 Aug; 42(6):2373-2380. PubMed ID: 35611871
[TBL] [Abstract][Full Text] [Related]
40. Modulating Intrafollicular Hormonal Milieu in Controlled Ovarian Stimulation: Insights From PPAR Expression in Human Granulosa Cells.
Tatone C; Benedetti E; Vitti M; Di Emidio G; Ciriminna R; Vento ME; Cela V; Borzì P; Carta G; Lispi M; Cimini AM; Artini PG;
J Cell Physiol; 2016 Apr; 231(4):908-14. PubMed ID: 26332656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
